Clinical and Transcriptional Profiles Reveal the Treatment Effect of Adalimumab in Patients with Initial-Onset and Recurrent Vogt-Koyanagi-Harada Disease.

已完结 10 由 Franco 发布于 2026/4/1 19:32:46

DOI:10.1080/09273948.2024.2346814
作者：Kailei Guo,?Xuanrong Xu,?Fuhua Yang,?Kaixuan Wang,?Xiaomin Zhang
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Purpose: We aimed to evaluate adalimumab efficacy in patients with initial-onset or recurrent Vogt-Koyanagi-Harada (VKH) syndrome.Methods: A retrospective clinical study was performed to exa

应助信息

1天前

heqiang

94cff4942dbf11f19a4434735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/4/1 19:32:46 未找到该文献，机器人已退出，请等待人工下载

2026/4/1 19:32:46 Book学术AI机器人收到请求，开始寻找文献

2026/4/1 19:32:46 已向机器人发送请求

1天前

Franco 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Proceedings of the National Academy of Sciences of the United States of America (PNAS)Identifying key convection-sensitive oceanic regions to weaken the ENSO spring predictability barrier